Dental Defense Solution (DDS) has been tested by multiple independent laboratories and is shown to neutralize periodontal pathogens
The ingredients in DDS are also individually clinically proven to address the root causes of dental work failure
Dental Defense Solution (DDS) has been tested by multiple independent laboratories and is shown to neutralize periodontal pathogens
The ingredients in DDS are also individually clinically proven to address the root causes of dental work failure
Test: The UK Department of Periodontics assessed Dental Defense Solution's ability to reduce biofilm on common dental work surfaces, including caps/crowns (polished zirconia), implants (titanium), and hydroxyapatite. DDS was applied to these surfaces for 30 seconds once daily for 10 days (5 days for mature biofilm) and reviewed under SEM.
Result: "Application of Dental Defense Solution significantly reduced bacterial growth on all three surfaces, including diseased samples in early and late stages of maturity, as compared to the control. Even on rough surfaces, such as implant threads and the inside of a crown, there was a significant decrease in biofilm density with the application of the Mouthwash. Furthermore, when applied late to diseased, mature biofilm, the Mouthwash still resulted in significantly less bacterial growth after just five exposures. We specifically noted a significant decrease in pathogenic-like bacteria after exposure to the Mouthwash, indicating effectiveness of the Mouthwash on dental work surfaces." Full report available upon request.
Drag sliders below to compare surfaces with and without the application of DDS (Coloring for illustrative purposes only)
Without DDS
With DDS
Without DDS
With DDS
Without DDS
With DDS
Test: The antimicrobial properties of Dental Defense Solution on key pathogenic organisms was assessed using a kill-time study.
Result: "Dental Defense Solution indicates a 99.99% reduction of all tested pathogens in 30 seconds." View Full Report.
The aim of this clinical trial was to assess the inhibitory effects of a mouthwash containing 0.1% ClO2 used for 2 weeks on gram-negative bacteria , gram-positive bacteria, oral malodor, periodontal status, salivary parameters and tongue coating.
This double blind randomized study evaluated antiplaque and antigingivitis properties of CPC compared to other rinses.
This is a randomized controlled clinical trial designed to develop and test a "Mouth Rinse Intervention" among pregnant women to prevent the progression of periodontal disease during pregnancy and reduce adverse birth and neonatal outcomes.
This study assess the antiplaque characteristics of chlorine dioxide-containing mouthrinse compared to chlorhexidine (CHX)-containing mouthrinse.
This study aims to evaluate the effect of aloe vera, chlorine dioxide, and chlorhexidine mouth rinses on plaque and gingivitis in orthodontic patients.
The aim of this study is to define clinical and histologic characteristics of peri-implant tissues in health and describe the mucosa–implant interface.
This study reviews differences in the subgingival microbiota of titanium implants with peri-implantitis as compared to implants surrounded by healthy tissues.
The purpose of this manuscript is to comprehensively review peri-implant diseases, their characteristics, as well as their non-surgical and surgical treatment.
This paper reviews the literature on nonsurgical treatment of non-healing medication related osteonecrosis of the jaw (MRONJ) utilizing a phosphate buffer-stabilized 0.1% chlorine dioxide mouthrinse.
This goal of this meta-analysis is to summarize the evidence on the effectiveness of xylitol-containing products in dental caries prevention with a focus on dental caries as the primary outcome rather than other pseudo outcomes.
This comprehensive review discusses the health benefit of xylitol.
The objective of this study is to evaluate the the anti-inflammatory effects of xylitol; possible use in the prevention and treatment of periodontal infections.
This study evaluates the clinical and microbiological efficacy of chlorine dioxide (ClO2) as a topical antiseptic for the treatment of chronic atrophic candidiasis.